News

The MINSA included in the PNUME for the Health Sector, the product Medicinal Oxygen 93% gas for inhalation

El Ministerio de Salud a través de la R.M. Nº 918-2020/MINSA, publicada el 09 de noviembre del 2020 en el Diario Oficial “El Peruano”, incluyó en el “Documento Técnico: Petitorio Nacional Único de Medicamentos Esenciales para el Sector Salud, el producto Oxígeno Medicinal 93% gas para inhalación para el uso por especialista en base a Guías de Práctica Clínica o Norma Técnica de Salud”.

Mayor información en el enlace de la fuente de referencia.

Full Technical Document: Click aqui

Fuente de referencia: Click aqui

Source: Official Gazette "El Peruano"

Recent posts

The MINSA included in the PNUME for the Health Sector, the product Medicinal Oxygen 93% gas for inhalation

MINSA ordered the publication of the Regulation Project that establishes specific provisions for conducting Clinical Trials with Medical Devices

The MINSA approved the Sanitary Directive for the use of Oxygen in Institutions Providers of Health Services and home use

MINSA approved the Technical Document: National Vaccination Plan against COVID-19

The MINSA orders the publication of the Technical Document project: Manual of Citizen Participation in the elaboration of the PNUME

MINSA approved the Technical Document: Management of people affected by COVID-19 in hospitalization services

MINSA approved the technical document: Guidelines for the exceptional health authorization of medical devices in the research stage

Urgent decree that dictates extraordinary measures to facilitate and guarantee the acquisition, conservation and distribution of vaccines against COVID-19

The MINSA plans to publish a draft ministerial resolution that resolves to include in the PNUME for the health sector, the medicinal oxygen product 93% gas

DIGEMID safety modifications: For pharmaceutical specialties containing "MELOXICAM"

The MINSA approves the update of the scale for infractions and sanctions to pharmaceutical and non-pharmaceutical establishments of the regulation of pharmaceutical establishments

DIGEMID safety modifications: For pharmaceutical products containing "Bacillus Clausii"

DIGEMID safety modifications: For pharmaceutical specialties containing "MONTELUKAST"

DIGEMID safety modifications: For pharmaceutical specialties containing "LORCASERIN"

DIGEMID safety modifications: For pharmaceutical specialties that contain "FENOTEROL"

El MINSA modificó el reglamento de estupefacientes, psicotrópicos y otras sustancias sujetas a fiscalización sanitaria

The MINSA approved the "Technical Health Standard that establishes the ethical criteria for the promotion and advertising of pharmaceutical products, medical devices and health products"

Health Directive for the control and surveillance of in vitro diagnostic devices is approved: Rapid and molecular tests for COVID-19

The MINSA incorporated the sheet called: IVERMECTINA oral solution 6 mg/ml in the technical health standard for the preparation of pharmaceutical preparations

El MINSA incorporó productos farmacéuticos al listado de bienes esenciales para el manejo y tratamiento del COVID-19